Adjuvant Capital Gp, L.p. - Net Worth and Insider Trading
Adjuvant Capital Gp, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Adjuvant Capital Gp, L.p. owns 1 companies in total, including AN2 Therapeutics Inc (ANTX) .
Click here to see the complete history of Adjuvant Capital Gp, L.p.’s form 4 insider trades.
Insider Ownership Summary of Adjuvant Capital Gp, L.p.
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| ANTX | AN2 Therapeutics Inc | 2022-03-24 | 10 percent owner |
Adjuvant Capital Gp, L.p. Trading Performance
Adjuvant Capital Gp, L.p. Ownership Network
Ownership Network List of Adjuvant Capital Gp, L.p.
Ownership Network Relation of Adjuvant Capital Gp, L.p.
Adjuvant Capital Gp, L.p. Owned Company Details
What does AN2 Therapeutics Inc do?
Who are the key executives at AN2 Therapeutics Inc?
Adjuvant Capital Gp, L.p. is the 10 percent owner of AN2 Therapeutics Inc. Other key executives at AN2 Therapeutics Inc include Chief Development Officer Sanjay Chanda , Chief Financial Officer Lucy Day , and See Remarks Joshua M Eizen .
AN2 Therapeutics Inc (ANTX) Insider Trades Summary
Over the past 18 months, Adjuvant Capital Gp, L.p. made no insider transaction in AN2 Therapeutics Inc (ANTX). Other recent insider transactions involving AN2 Therapeutics Inc (ANTX) include a net purchase of 329,906 shares made by Robin Shane Readnour , a net sale of 73,000 shares made by Joseph S Zakrzewski , and a net sale of 1,032,000 shares made by Braden Michael Leonard .
In summary, during the past 3 months, insiders sold 2,532,000 shares of AN2 Therapeutics Inc (ANTX) in total and bought 8,610 shares, with a net sale of 2,523,390 shares. During the past 18 months, 6,392,571 shares of AN2 Therapeutics Inc (ANTX) were sold and 1,920,610 shares were bought by its insiders, resulting in a net sale of 4,471,961 shares.
AN2 Therapeutics Inc (ANTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
AN2 Therapeutics Inc Insider Transactions
Adjuvant Capital Gp, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Adjuvant Capital Gp, L.p.. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Adjuvant Capital Gp, L.p.'s mailing address is: New York Ny 10017.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
